Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease Potential for Targeting Inflammation With Canakinumab

被引：12
|
作者：
Cherney, David Z. I. [1 ,2 ]
Lytvyn, Yuliya [1 ,2 ]
McCullough, Peter A. [3 ]
机构：
[1] Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[3] Baylor Univ, Med Ctr, Baylor Heart & Vasc Hosp, Dallas, TX USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 21期
关键词：
canakinumab; cardiovascular risk; CKD; inflammation; C-REACTIVE PROTEIN; INTERLEUKIN-1-BETA INHIBITION;
D O I：
10.1016/j.jacc.2018.04.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2415 / 2418
页数：4
相关论文
共 50 条
  • [1] Role of nutrition for cardiovascular risk reduction in chronic kidney disease patients
    Ikizler, TA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (02) : 162 - 171
  • [2] Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
    Ridker, Paul M.
    MacFadyen, Jean G.
    Glynn, Robert J.
    Koenig, Wolfgang
    Libby, Peter
    Everett, Brendan M.
    Lefkowitz, Martin
    Thuren, Tom
    Cornel, Jan H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (21) : 2405 - 2414
  • [3] Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis
    Kochi, Masako
    Kohagura, Kentaro
    Shiohira, Yoshiki
    Iseki, Kunitoshi
    Ohya, Yusuke
    JOURNAL OF CARDIOLOGY, 2018, 71 (3-4) : 277 - 283
  • [4] Inflammation and Arterial Stiffness as Drivers of Cardiovascular Risk in Kidney Disease
    Lo Cicero, Lorenzo
    Lentini, Paolo
    Sessa, Concetto
    Castellino, Niccolo
    D'Anca, Ambra
    Torrisi, Irene
    Marcantoni, Carmelita
    Castellino, Pietro
    Santoro, Domenico
    Zanoli, Luca
    CARDIORENAL MEDICINE, 2025, 15 (01) : 29 - 40
  • [5] Potential contribution of monounsaturated fatty acids to cardiovascular risk in chronic kidney disease
    Mika, Adriana
    Sikorska-Wisniewska, Malgorzata
    Malgorzewicz, Sylwia
    Stepnowski, Piotr
    Debska-Slizien, Alicja
    Sledzinski, Tomasz
    Chmielewski, Michal
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (12): : 755 - 763
  • [6] Cardiovascular risk prediction in chronic kidney disease patients
    Cedeno Mora, Santiago
    Goicoechea, Marian
    Torres, Esther
    Verdalles, Ursula
    Perez de Jose, Ana
    Verde, Eduardo
    Garcia de Vinuesa, Soledad
    Luno, Jose
    NEFROLOGIA, 2017, 37 (03): : 293 - 300
  • [7] Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease
    Peev, Vasil
    Nayer, Ali
    Contreras, Gabriel
    CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (01) : 54 - 60
  • [8] Biomarkers Determining Cardiovascular Risk in Patients with Kidney Disease
    Siasos, G.
    Tousoulis, D.
    Michalea, S.
    Oikonomou, E.
    Kolia, C.
    Kioufis, S.
    Synetos, A.
    Vlasis, K.
    Papavassiliou, A. G.
    Stefanadis, C.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (16) : 2555 - 2571
  • [9] Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
    Sin, DD
    Man, SFP
    CIRCULATION, 2003, 107 (11) : 1514 - 1519
  • [10] Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease
    Silverstein, Douglas M.
    PEDIATRIC NEPHROLOGY, 2009, 24 (08) : 1445 - 1452
12345